Skip to main content
Mark A. Hyde
( out of 42 reviews )

Mark A. Hyde, PhD, PA-C

Languages spoken: English, Russian

Clinical Locations

Sugar House Health Center

Salt Lake City
801-581-2000

University of Utah Hospital

Dermatology, Area E
Salt Lake City
801-581-2955
  • Mark Hyde, PhD, PA-C has specialized expertise in the treatment of patients with skin diseases including melanoma and non-melanoma skin cancer. As a Physician Assistant, he is board certified in primary care. Dr. Hyde has assisted in Mohs micrographic surgery, having performed more than 9000 procedures at the Huntsman Cancer Institute.

    Patient Rating

    5.0 /5
    ( out of 42 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 31, 2024
    STANSBURY HEALTH CENTER

    Makes you feel very comfortable, very friendly, and cares about his patients

    October 29, 2024
    SUGAR HOUSE HEALTH CENTER

    Very good doctor! And Assistants

    October 14, 2024
    SUGAR HOUSE HEALTH CENTER

    helpful and insightful

    October 10, 2024
    STANSBURY HEALTH CENTER

    Mark is very knowledgeable about acnes and skin care and assisted me to get back into a plan of care to address my life long battle with cystic acne.

    October 04, 2024
    STANSBURY HEALTH CENTER

    Mark Hyde is one of a kind provider. He is very knowledgeable, understanding, and caring. He explained my treatment plan where I could understand and explain in detail what my medication would do for me. I would highly recommend Mark

    October 04, 2024
    SUGAR HOUSE HEALTH CENTER

    Very freindly and courteous. Good bedside manner. Would recommend.

    October 04, 2024
    STANSBURY HEALTH CENTER

    mark a hyde is a wonderfull DR..

    October 03, 2024
    STANSBURY HEALTH CENTER

    Mark Hyde was quick with my appointment but it wasn't rushed. He took his time explaining to me what my skin issue is and how we can work together to fix it. I appreciated him and his team.

    October 03, 2024
    STANSBURY HEALTH CENTER

    He is very professional and worked diligently tiding the cause of my rash and to provide the treatment that I need.

  • Mark Hyde, PhD, PA-C has specialized expertise in the treatment of patients with skin diseases including melanoma and non-melanoma skin cancer. As a Physician Assistant, he is board certified in primary care. Dr. Hyde has assisted in Mohs micrographic surgery, having performed more than 9000 procedures at the Huntsman Cancer Institute.

    Board Certification and Academic Information

    Academic Departments Dermatology -Primary

    Education history

    Certification Genetics/Genomics - Stanford Certificate
    Public Health and Epidemiology - University of Utah Ph.D.
    Graduate Training Physician Assistant - Midwestern University M.M.Sc.
    Political Science - University of Utah B.A.

    Selected Publications

    Journal Article

    1. Ruiz J, Hyde M, Perry A, Brouha B (2023). Genomic Evaluation of Clinically Ambiguous Pigmented Lesions. J Clin Aesthet Dermatol, 16(6), 44-45. (Read full article)
    2. Hyde MA, Grossman D, Wu YP, Buys S, Gren LH, Hashibe M (2020). Vitamin D, melanoma risk, and tumor thickness in PLCO cancer screening trial patients. JAAPA, 33(6), 35-41. (Read full article)
    3. Clark JJ, Woodcock A, Cipriano SD, Hyde MA, Edwards SL, Frost CJ, Eliason MJ (2016). Community perceptions about the use of black salve. J Am Acad Dermatol, 74(5), 1021-3. (Read full article)
    4. Thomas E, Coombs J, Kim J, Hyde M (Summer 2014). Physician Assistants in Dermatology: A Survey of Fellows of the SDPA. 8(3), 47-48.
    5. Gaffney S, Goldgar C, Hyde M (2012). Roles and responsibilities of physician assistants practicing in Mohs surgery. JAAPA, 25(10), 52. (Read full article)
    6. Hyde MA, Hadley ML, Tristani-Firouzi P, Goldgar D, Bowen GM (2012). A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisions. Arch Dermatol, 148(5), 592-6. (Read full article)
    7. Gifford A, Hyde M, Stoehr JD (2011). PAs in the ED: do physicians think they increase the malpractice risk? JAAPA, 24(6), 34, 36-8. (Read full article)
    8. Hyde MA, Hadley ML, Roberson C, Jacobson A, Pappas L, Bowen GM (2010). Use of physician assistants in Mohs micrographic surgery: a survey of fellowship-trained Mohs micrographic surgeons. Dermatol Surg, 36(11), 1700-3. (Read full article)
    9. Goodson AG, Florell SR, Hyde M, Bowen GM, Grossman D (2010). Comparative analysis of total body and dermatoscopic photographic monitoring of nevi in similar patient populations at risk for cutaneous melanoma. Dermatol Surg, 36(7), 1087-98. (Read full article)

    Letter

    1. Duffy KL, Truong A, Bowen GM, Andtbacka RH, Hyngstrom J, Bowles T, Grossmann K, Khong H, Hyde M, Florell SR, Bowen AR, Wada D, Grossman D (2014). Adequacy of 5-mm surgical excision margins for non-lentiginous melanoma in situ. [Letter to the editor]. J Am Acad Dermatol, 71(4), 835-8. (Read full article)
    2. Duffy K, Hyde MA, Tanner B, Goldgar D, Bowen AR, Florell SR, Bowen GM (2010). Anatomic variability in superficial blood vessel and lymphatic vessel density. [Letter to the editor]. J Cutan Pathol, 37(10), 1108-9. (Read full article)

    Other

    1. Mark Hyde, PhD, PA-C (2024). Elevate-Derm ALLIANCE Estrogen-Related Skin Tumors - Connection to Gender Transition?